STELLUS CAPITAL MANAGEMENT, LLC PROVIDES UNITRANCHE FINANCING IN SUPPORT OF BERNHARD CAPITAL PARTNERS' INVESTMENT IN REVENEW INTERNATIONAL

Stellus Capital Management provided senior debt financing and an equity co-investment to support Bernhard Capital Partners' acquisition of Revenew International. Revenew provides contract-compliance, profit-recovery and performance-consulting services to asset-intensive sectors including utilities, energy, manufacturing, mining, pharmaceuticals and chemicals. The financing is structured to support continued growth, supported by Revenew's technology-enabled delivery model, proprietary data platform and recurring customer relationships.

Analysis

For SCM, the transaction is directionally constructive but unlikely to be earnings-material without disclosure of commitment size, pricing, leverage, or funded amount. The relevant signal is portfolio construction: a senior secured loan coupled with equity participation can enhance risk-adjusted returns if the equity kicker is meaningful, but it also creates greater downside correlation in a sponsor-owned, services-heavy borrower. Given SCM's externally managed BDC structure, the market will focus less on deal announcements than on whether new originations sustain net investment income above the distribution while preserving non-accruals and NAV.

The underlying business model has defensiveness in a softer industrial environment because clients may fund recovery audits from identified savings rather than discretionary budgets. That said, contingency-fee revenue can be volatile, and a prolonged downturn in utilities, chemicals, mining, or manufacturing could reduce vendor spend, contract complexity, and recovery opportunities. Bernhard's operational expertise may improve execution, but sponsor-backed growth plans can also introduce leverage and add-on acquisition risk that is not visible in the release.

Near term, this is not a standalone catalyst for SCM; the 1-3 month catalyst is quarterly disclosure of deal size, yield, first-lien status, and any equity valuation marks. Over 6-18 months, the trade becomes constructive only if SCM demonstrates continued high-spread originations without a rise in PIK income, watch-list credits, or NAV erosion. Consensus may overread private-credit deployment as inherently bullish: rapid portfolio growth late in a credit cycle can lift NII initially while embedding future credit losses.

Key Decisions for Investors

• No immediate directional trade on the announcement alone; place SCM on an earnings watch list and require disclosure of funded principal, cash yield, leverage multiple, and equity co-investment size before underwriting incremental upside.
• If SCM trades at a discount to NAV and next quarterly results show cash NII covering the distribution by at least 105%, stable-to-higher NAV, and no increase in non-accruals, initiate a 6-12 month long SCM position; target a rerating toward NAV plus the dividend carry, with downside stop if NAV declines more than 3% sequentially.
• Avoid treating the equity co-investment as pure upside: reduce or hedge a prospective SCM long if PIK income rises, non-accruals exceed management's recent range, or the new investment is marked below cost within the first two reporting periods.
• For broader private-credit exposure, prefer a quality-screened basket rather than concentrating in SCM until portfolio-level concentration and sponsor underwriting terms are disclosed; a widening of BDC credit spreads or a risk-off move in leveraged loans would be the near-term thesis invalidator.